XML 31 R17.htm IDEA: XBRL DOCUMENT v3.6.0.2
SHARE-BASED PAYMENT
12 Months Ended
Dec. 31, 2016
SHARE-BASED PAYMENT  
Share-Based Payment

NOTE 11—SHARE-BASED PAYMENT

 

As of December 31, 2016, there were 8.5 million shares of stock authorized for issuance to directors, officers, and employees under the 2015 Equity Incentive Plan. At December 31, 2016,  2.9 million shares remain available for grant under the 2015 Equity Incentive Plan.

 

During 2016,  2015, and 2014, the Company granted stock options to executive officers under the 2015 Equity Incentive Plan and restricted shares to officers, employees, and non-employee directors, without cost to the grantee. During 2016,  2015, and 2014, the Company also granted 0.5 million, zero, and 0.6 million RSUs, respectively, to the officers and certain other employees in connection with PSPs. The Company granted the RSUs at the maximum performance thresholds for each metric each year. As of December 31, 2016, all of these RSUs are unvested and outstanding.

 

The performance period for the 2014 PSP concluded on December 31, 2016. The two performance goals related to the 2014 PSP were met at varying levels. Accordingly, 0.6 million shares related to the 2014 PSP vested in the first quarter of 2017. As of December 31, 2016, the Company concluded that the three performance targets related to the 2016 PSP were probable of achievement at varying levels.

 

The following table summarizes stock compensation expense for the years ended December 31, 2016, 2015, and 2014:

 

 

 

 

 

 

 

 

 

 

 

 

Components of stock compensation expense (in thousands)

    

2016

    

2015

    

2014

  

Restricted shares

 

$

10,272

 

$

8,214

 

$

7,105

 

Stock options

 

 

1,768

 

 

1,957

 

 

1,878

 

2014 PSP

 

 

3,625

 

 

3,913

 

 

1,011

 

2016 PSP

 

 

2,812

 

 

 —

 

 

 —

 

Total stock compensation expense

 

$

18,477

 

$

14,084

 

$

9,994

 

 

 

 

 

 

 

 

 

 

 

 

Excess tax benefit (shortfall) recognized

 

$

631

 

$

1,410

 

$

(38)

 

 

The restricted shares amounts in the table above include both equity-classified awards granted in restricted shares and liability-classified awards to be granted in restricted shares.

 

The following table summarizes restricted share activity for the year ended December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant-date

 

Restricted Shares

    

Shares

    

Fair Value

 

Nonvested at January 1, 2016

 

1,312,774

 

$

19.99

 

Granted

 

645,533

 

 

21.51

 

Vested

 

(452,856)

 

 

19.38

 

Forfeited

 

(23,968)

 

 

27.78

 

Nonvested at December 31, 2016

 

1,481,483

 

$

20.71

 

 

The fair value of restricted share awards granted during 2016 was estimated using the closing price on the date of grant. The weighted average grant date fair values of restricted shares granted in 2015 and 2014 were $21.03 per share and $16.60 per share, respectively. The fair values of the restricted shares that vested during the years ended December 31, 2016, 2015, and 2014 were $10.3 million, $9.6 million, and $6.2 million, respectively.

 

As of December 31, 2016, the total unrecognized compensation cost for outstanding restricted shares was $17.5 million. As of December 31, 2016, the weighted-average period over which the unrecognized compensation cost will be recognized is 2.8 years.

 

The following table summarizes stock options activity for the year ended December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

Weighted-

 

Average

 

Aggregate

 

 

 

 

 

Average

 

Remaining

 

Intrinsic

 

 

 

 

 

Exercise

 

Contract Life

 

Value

 

Stock Options

    

Options

    

Price

    

(Years)

    

(in thousands)

 

Outstanding at January 1, 2016

 

1,106,352

 

$

16.30

 

 

 

 

 

 

Granted

 

207,180

 

 

20.40

 

 

 

 

 

 

Exercised

 

(18,157)

 

 

26.97

 

 

 

 

 

 

Forfeited

 

 —

 

 

 —

 

 

 

 

 

 

Expired

 

 —

 

 

 —

 

 

 

 

 

 

Outstanding at December 31, 2016

 

1,295,375

 

$

16.97

 

7.0

 

$

18,436

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2016

 

815,080

 

$

16.14

 

6.2

 

$

12,279

 

 

The total intrinsic value of the stock options exercised during the years ended December 31, 2016,  2015, and 2014 was $0.2 million, $2.6 million, and less than $0.1 million, respectively. We received no cash from the exercise of options for each of the years ended December 31, 2016, 2015, and 2014.

 

As of December 31, 2016, the total unrecognized compensation cost for outstanding options was $1.7 million. As of December 31, 2016, the weighted-average period over which the unrecognized compensation cost will be recognized is 1.7 years.

 

The fair value of stock option awards granted during 2016,  2015, and 2014 were estimated on the grant date using the Black-Scholes option pricing model, based on the following inputs:

 

 

 

 

 

 

 

 

 

 

 

 

    

2016

    

2015

    

2014

  

Estimated option life

 

 

6.00 years

 

 

6.00 years

 

 

6.00 years

 

Risk free interest rate

 

 

1.31

%

 

1.68

%

 

1.86

%

Expected volatility

 

 

34.42

%

 

33.48

%

 

35.35

%

Expected dividend rate

 

 

0.00

%

 

0.00

%

 

0.00

%

Weighted average grant date fair value per share of options granted

 

$

7.21

 

$

5.90

 

$

6.35